Leonard John M

President and CEO, DirectorIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Aug 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$287K
Net Open-Market Flow
-$287K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2026Sell(S)3K$13.00$36K1.1M
Aug 20, 2026Sell(S)20K$12.60$251K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-363567) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about NTLA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-363567"
Ask your agent
Use Arkolith to summarize insider buying and selling at Intellia Therapeutics, Inc.
over the last 90 days and cite the filings.